QQQ   425.65 (-0.04%)
AAPL   168.11 (+0.07%)
MSFT   407.82 (-0.98%)
META   502.87 (+1.76%)
GOOGL   154.84 (-0.41%)
AMZN   180.05 (-0.68%)
TSLA   149.70 (-3.70%)
NVDA   828.00 (-1.47%)
AMD   152.46 (-1.01%)
NIO   3.88 (-0.77%)
BABA   68.95 (+0.19%)
T   16.15 (+0.19%)
F   12.05 (+0.08%)
MU   114.76 (-1.35%)
GE   156.69 (+0.66%)
CGC   6.50 (+0.15%)
DIS   113.35 (+0.36%)
AMC   2.87 (-3.69%)
PFE   25.40 (-0.08%)
PYPL   62.92 (-0.54%)
XOM   119.11 (+0.40%)
QQQ   425.65 (-0.04%)
AAPL   168.11 (+0.07%)
MSFT   407.82 (-0.98%)
META   502.87 (+1.76%)
GOOGL   154.84 (-0.41%)
AMZN   180.05 (-0.68%)
TSLA   149.70 (-3.70%)
NVDA   828.00 (-1.47%)
AMD   152.46 (-1.01%)
NIO   3.88 (-0.77%)
BABA   68.95 (+0.19%)
T   16.15 (+0.19%)
F   12.05 (+0.08%)
MU   114.76 (-1.35%)
GE   156.69 (+0.66%)
CGC   6.50 (+0.15%)
DIS   113.35 (+0.36%)
AMC   2.87 (-3.69%)
PFE   25.40 (-0.08%)
PYPL   62.92 (-0.54%)
XOM   119.11 (+0.40%)
QQQ   425.65 (-0.04%)
AAPL   168.11 (+0.07%)
MSFT   407.82 (-0.98%)
META   502.87 (+1.76%)
GOOGL   154.84 (-0.41%)
AMZN   180.05 (-0.68%)
TSLA   149.70 (-3.70%)
NVDA   828.00 (-1.47%)
AMD   152.46 (-1.01%)
NIO   3.88 (-0.77%)
BABA   68.95 (+0.19%)
T   16.15 (+0.19%)
F   12.05 (+0.08%)
MU   114.76 (-1.35%)
GE   156.69 (+0.66%)
CGC   6.50 (+0.15%)
DIS   113.35 (+0.36%)
AMC   2.87 (-3.69%)
PFE   25.40 (-0.08%)
PYPL   62.92 (-0.54%)
XOM   119.11 (+0.40%)
QQQ   425.65 (-0.04%)
AAPL   168.11 (+0.07%)
MSFT   407.82 (-0.98%)
META   502.87 (+1.76%)
GOOGL   154.84 (-0.41%)
AMZN   180.05 (-0.68%)
TSLA   149.70 (-3.70%)
NVDA   828.00 (-1.47%)
AMD   152.46 (-1.01%)
NIO   3.88 (-0.77%)
BABA   68.95 (+0.19%)
T   16.15 (+0.19%)
F   12.05 (+0.08%)
MU   114.76 (-1.35%)
GE   156.69 (+0.66%)
CGC   6.50 (+0.15%)
DIS   113.35 (+0.36%)
AMC   2.87 (-3.69%)
PFE   25.40 (-0.08%)
PYPL   62.92 (-0.54%)
XOM   119.11 (+0.40%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$11.52
$11.50
$5.57
$11.98
$397.94M1.11106,940 shs9,831 shs
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
$0.02
+7.4%
$0.02
$0.01
$3.47
$1.14M1.57281,029 shs310,800 shs
HemaCare Co. stock logo
HEMA
HemaCare
$25.31
+0.6%
$25.31
$8.62
$26.23
$346.52M1.4739,950 shs5,400 shs
PFHOD
Pacific Health Care Organization
$1.25
-69.5%
$1.25
$1.11
$5.90
$16M0.941,720 shs2,100 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00%0.00%0.00%0.00%0.00%
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
0.00%0.00%0.00%-12.80%-99.08%
HemaCare Co. stock logo
HEMA
HemaCare
0.00%0.00%0.00%0.00%0.00%
PFHOD
Pacific Health Care Organization
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/AN/AN/AN/A
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/AN/AN/AN/AN/A
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/A
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/A
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$822.52M0.48$1.69 per share6.80$2.59 per share4.45
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
$1.27M0.90N/AN/A($14.93) per share0.00
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
$6.80M2.35$0.11 per share11.21$0.63 per share1.98

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/A
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
-$58.79M-$9.23N/AN/AN/AN/AN/A-175.11%5/10/2024 (Estimated)
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/A0.00N/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
$1.36MN/A0.00N/A16.87%14.47%12.96%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/A
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/AN/A
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
7.54
1.05
1.02
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/A
0.07
0.07
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/A
PFHOD
Pacific Health Care Organization
0.05
12.91
12.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
78.42%
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
9.05%
HemaCare Co. stock logo
HEMA
HemaCare
N/A
PFHOD
Pacific Health Care Organization
N/A

Insider Ownership

CompanyInsider Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
9.50%
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
0.10%
HemaCare Co. stock logo
HEMA
HemaCare
26.20%
PFHOD
Pacific Health Care Organization
61.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
4,97734.54 millionN/AOptionable
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
952.46 million52.41 millionNot Optionable
HemaCare Co. stock logo
HEMA
HemaCare
N/A13.69 millionN/ANot Optionable
PFHOD
Pacific Health Care Organization
3912.80 millionN/ANot Optionable

ARA, HEMA, BXRX, and PFHOD Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

American Renal Associates logo

American Renal Associates

NYSE:ARA
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.
Baudax Bio logo

Baudax Bio

NASDAQ:BXRX
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.
HemaCare logo

HemaCare

OTCMKTS:HEMA
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, and cord blood; and a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company's network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California.

Pacific Health Care Organization

OTCMKTS:PFHOD
Pacific Health Care Organization, Inc., together with its subsidiaries, provides specialty workers' compensation managed care services for self-administered employers, insurers, third party administrators, municipalities, and others in the United States. The company is involved in managing health care organizations (HCOs) and medical provider networks (MPNs); and negotiating legal agreements for the implementation of workers' compensation carve-outs for California clients/employers with collective bargaining units. It also offers HCO and MPN programs; medical case management services; and ancillary services, including utilization and medical bill review, lien representation, legal support, Medicare set aside, and network access services for workers' compensation claims. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Newport Beach, California.